Long-term trial of an alpha adrenoceptor blocking drug (Indoramin) in asthma. A preliminary report.


Eight patients suffering from both asthma and migraine underwent a clinical trial for 3 months of indoramin, an alpha adrenoceptor antagonist with antihistamine and antiserotonin activity. Patients were told indoramin was prescribed for migraine prophylaxis. In three asthmatic patients there was a marked increase in airflow meter (AFM) readings which were… (More)


  • Presentations referencing similar topics